Funding for this research was provided by:
Health Technology Assessment Programme (12/28/05)
Received: 7 January 2019
Accepted: 10 September 2019
First Online: 13 November 2019
Ethics approval and consent to participate
: The STEPWISE project received ethics approval from Yorkshire and Humber - South Yorkshire NHS Research Ethics Committee (reference CitationRef removed/YH/0019) on 4 February 2014. Written informed consent for study participation was obtained from all service users as part of the consent process for the RCT. Service users and facilitators provided verbal consent which was audio-recorded prior to (and separately) from the telephone interviews and documented in writing on NHS REC-approved consent forms. A copy of the consent form was provided to all participants. Written informed consent for study participation for interventionists was obtained. A copy of the consent forms for service users, interventionists and facilitators are available for review by the Editor of this journal.
: Written informed consent for study participation, and publication of direct quotes, was obtained from all participants. A copy of the consent forms for service users, interventionists and facilitators are available for review by the Editor of this journal.
: DS is expert advisor to the NICE centre for guidelines and a member of the current NICE guideline development group for Rehabilitation in adults with complex psychosis and related severe mental health conditions; Board member of the National Collaborating Centre for Mental Health (NCCMH); Clinical Advisor (paid consultancy basis) to National Clinical Audit of Psychosis (NCAP); views are personal and not those of NICE, NCCMH or NCAP.RIGH received fees for lecturing, consultancy work and attendance at conferences from the following: Boehringer Ingelheim, Eli Lilly, Janssen, Lundbeck, Novo Nordisk, Novartis, Otsuka, Sanofi, Sunovion, Takeda, MSD.All remaining named authors did not disclose any declarations of interest.